I am the Youth Commission staff. We wanted to come through to show that we create change not by thinking of how good everything works for the privileged folks. We think about change in how it treats the people on the margins, undocumented folks, black and brown folks and transand gender, nonconforming folks. We cannot forget what happened with the gladiator case against the sheriff which supervisor walton called for a hearing on accountability of the Sheriffs Department about how are people currently being treated. Right now we are thinking about longstanding promises and this is the problem we need to address right here. You will have the position and power to do that. Please listen to the plans and recommendations made already. Thank you. Next speaker. Hello. I am Third Generation san franciscan. I am calling for a change. This doesnt go far enough. It will send people to santa rita is wrong. People die at santa rita. The fact most Vulnerable People are at 850 and we are thinking of
Criminal defenses. Whenever you are in the room you should see a lough red. You should see a little bit of blue and the little bit of blue you should see is around mitigation. In effective assistance of counsel mitigation, and soming aggravation. In general, its not working we again, remember its a subset of cases. It may be more effective in plea bargaining. In cases where theres good evidence of neurological or biological it may never get to trial. It may be a skewed sample. At least in the casing im looking at its not having a huge impact as of yet. Its causing people to ask a lot of questions. The amount of ink the people are spilling and trying to address these issues is increasing in volume. So its an issue that were going to have to address. So in conclusion, the use of this evidence is rapidly expanding, and were going have to figure out what it means for concept of responsibility and punishment. Its showing up in a lot of criminal cases. Primarily in sentencing but also in pre
/PRNewswire/ Soligenix, Inc. (NASDAQ: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing.
Common Stock Will Begin Trading on Split-Adjusted Basis on June 6, 2024 PRINCETON, N.J., May 31, 2024 /PRNewswire/ Soligenix, Inc. (NASDAQ: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical